221
Participants
Start Date
December 31, 2005
Study Completion Date
August 31, 2006
Vernakalant (oral)
Placebo comparator
Kardiologisk/endokrinologisk afd. E Frederiksberg Hospital, Frederiksberg
KAS Herlev, Herlev
Roskilde Amts Sygehus Koge, Køge
Medicinsk Afdeling Kolding Sygehus, Kolding
Aarhus Sygehus Kardiologisk Afd. A, Aarhus
Aalborg Sygehus Syd, Aalborg
Sygehus Vendsyssel Hjorring, Hjørring
Penn State Heart & Vascular Institute, Hershey
The Heart Center, P.C., Huntsville
Marshfield Clinic, Marshfield
Cardiovascular Consultants Medical Group, Inc., Walnut Creek
Foothills Hospital, Calgary
Centre Hospitalier de l'Université de Montréal (CHUM) Hôtel Dieu, Montreal
Bispebjerg Hospital, Copenhagen
KAS Gentofte Kardiologisk Afdeling, Hellerup
Reinier de Graaf Gasthuis, Delft
Catharina Ziekenhuis, Eindhoven
Medisch Spectrum Twente, Enschede
University Medical Center Groningen (UMCG), Groningen
Trial sectie Cardiologie, Heerlen
Academisch Ziekenhuis Maastricht, Maastricht
Stichting Sint Antonius Ziekenhuis, Nieuwegein
Lead Sponsor
Advanz Pharma
INDUSTRY